2009
DOI: 10.1016/j.jconrel.2009.02.014
|View full text |Cite
|
Sign up to set email alerts
|

A new model of resorbable device degradation and drug release: Transient 1-dimension diffusional model

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
39
0

Year Published

2010
2010
2016
2016

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 52 publications
(39 citation statements)
references
References 31 publications
0
39
0
Order By: Relevance
“…Various authors have proposed more advanced models for polymer degradation to take into account the interplay between hydrolysis and oligomer diffusion [20][21][22][23][24]. In particular, Perale et al [20] and Arosio et al [21] developed a polymer degradation model for solid devices by the description of polymer degradation kinetics coupled with the diffusion of water, monomers and oligomers through the polymeric matrix.…”
Section: Modifications To the Model Of Han And Pan [10]mentioning
confidence: 99%
See 1 more Smart Citation
“…Various authors have proposed more advanced models for polymer degradation to take into account the interplay between hydrolysis and oligomer diffusion [20][21][22][23][24]. In particular, Perale et al [20] and Arosio et al [21] developed a polymer degradation model for solid devices by the description of polymer degradation kinetics coupled with the diffusion of water, monomers and oligomers through the polymeric matrix.…”
Section: Modifications To the Model Of Han And Pan [10]mentioning
confidence: 99%
“…In particular, Perale et al [20] and Arosio et al [21] developed a polymer degradation model for solid devices by the description of polymer degradation kinetics coupled with the diffusion of water, monomers and oligomers through the polymeric matrix. Their model describes the evolution of the molecular weight distribution function through the device and during time.…”
Section: Modifications To the Model Of Han And Pan [10]mentioning
confidence: 99%
“…[19,20] However,e specially at lowd rug concentrations, severalo ther mechanisms, such as drug-polymer interactions, that could influencem ass transport take place and cannotb en eglected for an optimal deviced esign. [11] In this work, we studied the releaseo f sodiumf luorescein( SF), ac ommonly used drug-mimetic molecule, [21][22][23] chosen for itss terich indrance and its resemblance to many corticosteroids and anti-inflammatory drugs (for example,m ethylprednisolone, ibuprofen, and estradiol) used in pharmacotherapy. [24,25] Moreover,S Fm olecules present ac ommon tendency of anti-inflammatory drugs:a ggregation in dimers and trimers.…”
Section: Introductionmentioning
confidence: 99%
“…Through the coupling of these numerical methods, as displayed by the promising work of Zunino et al (2009), comprehensive models for the evaluation of stent performance in terms of its deployment characteristics influence on local vessel haemodynamics and effective drug-release may be developed. Furthermore, as bioabsorbable coronary stents such as the BVS everolimuseluting stent (Abbott Vascular, Santa Clara, CA, USA) continue to perform well in clinical evaluation (Serruys et al 2009), sophisticated numerical models capable of predicting both device degradation and drug-release from the device, such as that proposed by Perale et al (2009) will be required. It is possible that the development, adoption and coupling of each of these numerical methods may one day lead to their direct incorporation in clinical practice.…”
Section: Resultsmentioning
confidence: 99%